Novo Nordisk | NVO - Action





Action Changement Date
ANI Pharmaceuticals USD 143.47M 401K 2026-03
Aurora Cannabis CAD 230.56M 8.6M 2025-12
Bausch Health Companies USD 1.63B 31M 2025-12
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Canopy Growth CAD 105.56M 3.18M 2025-12
Corcept Therapeutics USD 12.89M 22K 2026-03
Drreddys Laboratories INR 79.01B 3.41B 2025-12
Eli Lilly USD 14.53B 785M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Merck USD 6.48B 179M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.29B 17M 2026-03
Novo Nordisk DKK 45.65B 21.26B 2025-06
Novo Nordisk DKK 42.85B 2B 2025-03
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Phibro Animal Health USD 539.7M 22.35M 2026-03
Prestige Brands USD 163.59M 4.6M 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
Zoetis USD 2.55B 120M 2026-03